NIDDK Funding for Multi-Center Clinical Studies through Cooperative Agreements

May 2023 Council

Lead Division/Office


Point(s) of Contact

Tracy Rankin; Aynur Unalp-Arida; Barbara Linder

Executive Summary

NIDDK currently supports the funding of high-risk multi-center clinical studies through a U34 planning grant followed by a separate application for the clinical trial or study (U01). High risk multi-center clinical study proposals cannot be submitted as regular investigator-initiated R01s. The current FOAs supporting the U34/U01 are expiring and will be reissued.